Evidence map›Paper›PMID 34862543›Full record

ArticleActa neurochirurgica. Supplement2022

Tackling the Complexity of Lesion-Symptoms Mapping: How to Bridge the Gap Between Data Scientists and Clinicians?

Emmanuel Mandonnet, Bertrand Thirion

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica. Supplement, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emmanuel MandonnetDepartment of Neurosurgery, Lariboisière Hospital, APHP, Paris, France. mandonnet@mac.com.
Bertrand ThirionInria, CEA, Université Paris-Saclay, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate and predictive lesion-symptoms mapping is a major goal in the field of clinical neurosciences. Recent studies have called for a reappraisal of the results given by the standard univariate voxel-based lesion-symptom mapping technique, emphasizing the need of developing multivariate methods. While the organization of large datasets and their analysis with machine learning (ML) approaches represents an opportunity to increase prediction accuracy, the complexity and dimensionality of the problem remain a major obstacle. Acknowledging the difficulty of inferring individual outcomes from the observation of spatial patterns of lesions, we propose here to base prediction on new individuals on models of brain connectivity, whereby the disruption of a given network predicts the occurrence of selective deficits. Well-suited ML tools are necessary to capture the relevant information from limited datasets and perform reliable inference.

Indexed as

BrainBrain MappingHumansMachine LearningMagnetic Resonance Imaging

Identifiers

PMID34862543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.